Filter Results
:
(231)
Show Results For
-
All HBS Web
(501)
- Faculty Publications (231)
Show Results For
-
All HBS Web
(501)
- Faculty Publications (231)
- October 2001 (Revised April 2002)
- Case
Calgene, Inc.
By: Ray A. Goldberg and John T. Gourville
In 1993, Calgene is on the verge of introducing the world's first genetically engineered plant product--a tomato will taste better and stay fresh longer. At the same time, it is using biotechnology to produce improved plant products for the cottonseed and the...
View Details
Keywords:
Information Technology;
Marketing Strategy;
Market Entry and Exit;
Product Launch;
Innovation Strategy;
Social Issues;
Production;
Problems and Challenges;
Biotechnology Industry;
Biotechnology Industry
Goldberg, Ray A., and John T. Gourville. "Calgene, Inc." Harvard Business School Case 502-041, October 2001. (Revised April 2002.)
- October 2001 (Revised March 2002)
- Case
Perlegen Sciences
By: Linda A. Hill and Nicole Tempest
As a biotech start-up company involved in studying human genomes, Perlegen needed to develop an organization that fostered innovation and teamwork among a group of highly trained professionals from both the science and technology fields. Perlegen's CEO, Brad Margus,...
View Details
Keywords:
Innovation Leadership;
Groups and Teams;
Management Teams;
Problems and Challenges;
Business Startups;
Genetics;
Talent and Talent Management;
Innovation Strategy;
Biotechnology Industry
Hill, Linda A., and Nicole Tempest. "Perlegen Sciences." Harvard Business School Case 402-026, October 2001. (Revised March 2002.)
- October 2001 (Revised March 2008)
- Case
Anagene, Inc.
By: Robert S. Kaplan and Christina L. Darwall
An entrepreneurial, publicly traded biotech company has begun production and sales of its core product--cartridges that permit DNA samples to be analyzed on a microchip. In the early quarters, sales are difficult to forecast and the company has experienced fluctuating...
View Details
Keywords:
Cost Accounting;
Financial Reporting;
Production;
Performance Capacity;
Risk and Uncertainty;
Genetics;
Governing and Advisory Boards;
Biotechnology Industry;
California
Kaplan, Robert S., and Christina L. Darwall. "Anagene, Inc." Harvard Business School Case 102-030, October 2001. (Revised March 2008.)
- September 2001
- Supplement
Millennium Pharmaceuticals, Inc. (B)
By: Stefan H. Thomke and Ashok Nimgade
Supplements the (A) case.
View Details
Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (B)." Harvard Business School Supplement 602-063, September 2001.
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process.
View Details
- 2001
- Other Unpublished Work
Clusters of Innovation Initiative: San Diego
The study contains a conceptual framework for assessing the competitiveness of regional economies, an analysis of the San Diego region overall, as well as detailed assessments of two representative clusters—biotechnology/pharmaceuticals and communications. The report...
View Details
Keywords:
Clusters;
Economics;
Industry Clusters;
Economy;
Growth and Development;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
San Diego
Porter, Michael E. "Clusters of Innovation Initiative: San Diego." Council on Competitiveness, Washington, DC, May 2001. (Report.)
- January 2001
- Case
Abgenix and the XenoMouse
By: Robert J. Dolan
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to...
View Details
Keywords:
Product Development;
Marketing Strategy;
Health Testing and Trials;
Risk and Uncertainty;
Technological Innovation;
Innovation Strategy;
Science-Based Business;
Biotechnology Industry
Dolan, Robert J. "Abgenix and the XenoMouse." Harvard Business School Case 501-061, January 2001.
- December 2000
- Case
Paradigm Genetics: The Industrialization of Genomics
By: Ray A. Goldberg, Carin-Isabel Knoop and Laure Mougeot Stroock
Goldberg, Ray A., Carin-Isabel Knoop, and Laure Mougeot Stroock. "Paradigm Genetics: The Industrialization of Genomics." Harvard Business School Case 901-011, December 2000.
- October 2000
- Teaching Note
Kendle International Inc. TN
By: Dwight B. Crane and Indra Reinbergs
Teaching Note for (9-200-033).
View Details
- 2000
- Chapter
In Search of Dynamic Capabilities: The Origins of R&D Competence in Biopharmaceuticals
By: Gary P. Pisano
Keywords:
Competency and Skills;
Research and Development;
Pharmaceutical Industry;
Pharmaceutical Industry
Pisano, Gary P. "In Search of Dynamic Capabilities: The Origins of R&D Competence in Biopharmaceuticals." Chap. 5 in The Nature and Dynamics of Organizational Capabilities, edited by Giovanni Dosi, Richard Nelson, and Sidney Winter, 129–154. New York: Oxford University Press, 2000.
- July 2000 (Revised April 2001)
- Case
Agricultural Biotechnology and its Regulation
In the United States, genetically modified corn and soybeans are now widely grown and consumed. In Europe, however, they have been dubbed "Frankenstein foods," shunned by packaged food manufacturers, and subjected to a host of governmental restrictions. This case...
View Details
Keywords:
Agribusiness;
Genetics;
Governing Rules, Regulations, and Reforms;
Corporate Strategy;
Trade;
Law;
Goods and Commodities;
Safety;
Environmental Sustainability;
Government and Politics;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry;
Europe;
United States
Reinhardt, Forest L. "Agricultural Biotechnology and its Regulation." Harvard Business School Case 701-004, July 2000. (Revised April 2001.)
- 27 Mar 2000
- Conference Presentation
Biotechnology Industry Organization Paper
By: Michael Porter
Keywords:
Biotechnology Industry
- February 2000 (Revised October 2000)
- Case
Kendle International Inc.
By: Dwight B. Crane, Paul W. Marshall and Indra Reinbergs
Candace Kendle and Christopher Bergen, the CEO and COO of Kendle International, Inc., are reviewing ways to finance the growth of their privately-owned company. Kendle is a contract research organization that conducts clinical drug trials for pharmaceutical and...
View Details
Keywords:
Acquisition;
Financing and Loans;
Venture Capital;
Stock Options;
Banks and Banking;
Debt Securities;
International Finance;
Financial Strategy;
Management Skills;
Private Ownership;
Initial Public Offering;
Biotechnology Industry;
Biotechnology Industry
Crane, Dwight B., Paul W. Marshall, and Indra Reinbergs. "Kendle International Inc." Harvard Business School Case 200-033, February 2000. (Revised October 2000.)
- December 1999 (Revised August 2001)
- Case
Millennium Pharmaceuticals, Inc. (A)
By: Stefan H. Thomke and Ashok Nimgade
Focuses on Millennium's strategy to grow and revolutionize drug development through the use of new technologies such as genomics. Describes how Millennium Pharmaceuticals--a fast-growing biotechnology firm in Cambridge, MA--has used strategic alliances to finance the...
View Details
Keywords:
Cost Management;
Financing and Loans;
Medical Specialties;
Retention;
Growth and Development Strategy;
Time Management;
Product Development;
Problems and Challenges;
Alliances;
Technology;
Biotechnology Industry;
Biotechnology Industry;
Cambridge
Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (A)." Harvard Business School Case 600-038, December 1999. (Revised August 2001.)
- November 1999
- Case
Seminis Inc.
By: Ray A. Goldberg, Jonathan West, Carin-Isabel Knoop and David Benedict Pearcy
Seminis became the world leader in vegetable seeds through a series of acquisitions. This case describes the Seminis strategy toward capturing value, biotechnology, and international operations.
View Details
Keywords:
Business Earnings;
Acquisition;
Profit;
Global Strategy;
Corporate Strategy;
Valuation;
Value Creation;
Biotechnology Industry
Goldberg, Ray A., Jonathan West, Carin-Isabel Knoop, and David Benedict Pearcy. "Seminis Inc." Harvard Business School Case 600-030, November 1999.
- October 1999
- Case
Agricultural Biotechnology Brief, 1999
By: Forest L. Reinhardt and Jennifer Burns
Keywords:
Business and Government Relations;
Environmental Sustainability;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry
Reinhardt, Forest L., and Jennifer Burns. "Agricultural Biotechnology Brief, 1999." Harvard Business School Case 700-066, October 1999.
- May 1999
- Teaching Note
Elliot Lebowitz TN
By: Paul A. Gompers
Teaching Note for (9-297-094).
View Details
Keywords:
Biotechnology Industry
- May 1999
- Teaching Note
Genset Initial Public Offering (A) & (B) TN
By: Paul A. Gompers
Teaching Note for (9-297-096) and (9-297-097).
View Details
- May 1999
- Teaching Note
Genset: 1989 TN
By: Paul A. Gompers
Teaching Note for (9-298-070).
View Details